BOSTON, May 15, 2019-- BHE, an innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners ("Silversmith") and Leerink Transformation Partners ("LTP"). The new funding will accelerate the development and market expansion of BHE's flagship Instant Health Data (IHD) platform, the market-leading real-world evidence (RWE) analytics solution currently being used by over two dozen major life science and research organizations. "We couldn't be more thrilled to partner with the Silversmith and LTP teams," said Joseph Menzin, Ph.D., Founder and CEO of BHE.